Motryx
Motryx provides VitalQC, a hardware-plus-software platform that uses a weight-matched surrogate blood vial and patented algorithms to validate and continuously monitor hospital pneumatic tube systems, helping clinical laboratories reduce pre-analytical hemolysis and sample rejection.
- Company typePrivate
- Founded2014
- HeadquartersHalifax, Canada
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Motryx does
Motryx Inc., founded in 2014 and headquartered in Halifax, Nova Scotia, provides VitalQC, a quality assurance platform that validates and continuously monitors hospital pneumatic tube systems (PTS) used to transport blood samples. The platform combines VitalVial — a hardware surrogate sample encapsulated in a blood-vial form factor, weight-matched to a real blood sample and instrumented with 3-axis accelerometers — with VitalApp, a cloud-based analytics application that runs patented algorithms translating transport vibration data into hemolysis index and analyte-specific sample rejection probabilities (LDH, AST, K) calibrated to each laboratory's chemistry analyzer. Motryx markets VitalQC primarily to hospital clinical laboratories and blood banks facing pre-analytical hemolysis, which the company cites as the cause of up to 70% of blood samples being unsuitable for diagnosis and over 75% of laboratory errors occurring before samples reach the analyzer.
The company generates revenue through three streams: annual VitalQC software subscriptions, VitalVial hardware sales as part of validation kits, and professional validation and consulting services. Its go-to-market combines enterprise field sales (free no-commitment trials, on-site demonstrations, scientific case studies) with channel partnerships covering eight major PTS manufacturers (Aerocom, Hanazeder, Swisslog, Sumetzberger, Pevco, Sarstedt, Tempus600) and a joint External Quality Assessment scheme with LabQuality. Motryx reports that 48 institutes across at least eight countries have validated PTS systems using VitalQC and that the platform has measured over 4,000 transits, with documented customer outcomes including a 53% reduction in rejection rates at Sheffield's Northern General Hospital and $70,000 per 10,000 tubes saved at Odense University Hospital.
Operationally, Motryx is a small founder-led company — three PhD founders plus additional staff in the 1-10 range — funded primarily through a ~$448K combination of non-dilutive Atlantic Canada Opportunities Agency grant and Creative Destruction Lab / WES Ecosystem Capital. The team operates without disclosed institutional venture capital and is not actively hiring, suggesting a capital-efficient, channel-partner-led growth model rather than a venture-scaling model.
Motryx firmographics
Firmographics- Name
- Motryx
- Legal name
- Motryx Inc.
- Website
- https://motryx.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Motryx provides VitalQC, a hardware-plus-software platform that uses a weight-matched surrogate blood vial and patented algorithms to validate and continuously monitor hospital pneumatic tube systems, helping clinical laboratories reduce pre-analytical hemolysis and sample rejection.
- Ownership category
- akta.pro rank
Motryx industry classification
Industry- Product category
- Laboratory Pre-Analytical Quality Assurance Software
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables) (HLAHAAAL)
- akta.pro secondary industries
- Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI), Diagnostic & Triage Decision Support (HLACAGAA)
Keywords
Where Motryx is headquartered
LocationHeadquarters
- HQ city
- Halifax
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Motryx business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- VitalQC Software/Subscription: Annual software subscription for VitalQC platform including VitalApp cloud analytics, automated reporting, and ongoing monitoring capabilities. Includes calibration to specific lab analyzers.
- VitalVial Hardware: Hardware device (VitalVial) sold as part of validation kits for hospital pneumatic tube system testing.
- Professional Services / Validation Services: Consulting and validation services for hospitals implementing or verifying pneumatic tube systems, including initial validation and ongoing verification.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Free no-commitment trial followed by enterprise subscription |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Motryx product offering
Product offeringCore offering
Motryx provides the VitalQC platform for clinically validating and continuously monitoring hospital pneumatic tube systems (PTS) used to transport blood samples. The platform combines the VitalVial hardware surrogate sample (a weight-matched blood-vial-form-factor device with embedded 3-axis accelerometers) with cloud-based VitalApp analytics and patented algorithms that translate transport vibration data into hemolysis index and analyte-specific sample rejection probability.
Product overview
Motryx offers a unified product ecosystem centered on VitalQC, a quality assurance platform for validating and monitoring hospital pneumatic tube systems (PTS). The portfolio consists of three integrated components: VitalQC (the core validation software), VitalApp (the analytics WebApp for data visualization and reporting), and VitalVial (a hardware surrogate sample device). VitalVial measures transport forces in actual PTS routes, while VitalQC's patented algorithms analyze the data and translate it into hemolysis index predictions and sample rejection probabilities, calibrated to specific laboratory analyzers. Results are delivered through VitalApp's intuitive interface.
Differentiator
Problem solved
Functional benefit
Brands
- VitalQC: Quality assurance tool for validating and monitoring pneumatic tube systems (PTS) for blood sample transport. Uses surrogate samples (VitalVial) to measure transport vibration and predict hemolysis index and sample rejection probability.
- VitalVial
- VitalApp
Products and services
- VitalQC Smart validation and continuous monitoring platform for hospital pneumatic tube systems (PTS), replacing outdated manual blood-based validation methods with an automated, analytics-based approach. Provides immediate reproducible quantitative and actionable validation metrics, including hemolysis index and analyte-specific rejection probability, calibrated to each lab's specific chemistry analyzer.
- VitalApp Web/desktop application that generates unique and immediate insights from VitalVial transport data, providing intuitive visualization of quality control outcomes and hemolysis prediction. Available for direct download on Windows and Mac from software.motryx.app.
- VitalVial Hardware surrogate sample encapsulated in a blood vial, weight-matched to a blood sample, with embedded 3-axis accelerometers that measure the g-forces and vibration blood samples experience during pneumatic tube transport.
Quantifiable outcome
- 87.5% time savings compared to traditional blood-based PTS validation
- +6 more outcomes
Companies that use Motryx
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles4 records
Motryx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Motryx partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- LabQualitycoreJoint offering of a new External Quality Assessment (EQA) scheme for Pre-analytics of Pneumatic Sample Transport. This extends quality assurance standards to the pre-analytical phase, addressing a gap in laboratory quality control programs.
- AerocomcorePartnership for joint provision of VitalQC as a quality assurance tool to validate pneumatic tube installations for safe and effective transport of blood samples. Aerocom is a global leader in Pneumatic Tube Systems. The partnership enables simple and reliable validation of PTS for blood sample integrity monitoring.
- University Hospitals (Europe and US)coreMotryx developed VitalQC in collaboration with university hospitals and reference centers in Europe and the US, helping laboratories establish appropriate validation criteria and repeatably verify against them. These collaborations underpin the scientific validation of VitalQC methodology.
Scale indicators12 records
Recent moves5 records
Expansion highlights5 records
Motryx competitors and assessment
Company assessmentDirect peers
- Bio-Rad Laboratories: Global leader in clinical laboratory quality control materials, calibrators, and proficiency testing programs. Closely comparable to Motryx in providing QC consumables and analytics used by hospital laboratories to verify IVD test reliability.
- Randox Laboratories: Manufactures third-party QC materials, calibrators, and EQA schemes for clinical laboratories, including the Acusera QC and RIQAS proficiency testing programs. Overlaps with Motryx on pre-analytical and analytical QC for hospital labs.
- Streck: Specializes in lab QC and sample stabilization products, including controls used to validate hematology and chemistry analyzers. Comparable niche focus on stabilizing and validating pre-analytical and analytical lab processes.
- Quantimetrix: Develops third-party quality control materials for clinical chemistry, immunoassay, and urinalysis. Directly comparable to Motryx in providing QC consumables that hospital labs use to ensure IVD test accuracy.
Broad incumbents
- Becton, Dickinson and Company (BD): Global medical technology incumbent with a dominant position in blood collection tubes and pre-analytical products. Comparable to Motryx in serving the pre-analytical workflow of clinical laboratories at much larger scale.
- Greiner Bio-One: Major manufacturer of blood collection tubes and pre-analytical consumables used in hospital laboratories. Operates in the same pre-analytical sample quality workflow that Motryx validates, but at broad incumbent scale.
- Roche Diagnostics: Global IVD incumbent with broad chemistry, immunoassay, and laboratory automation portfolios. Motryx's algorithms are calibrated to specific analyzers including those of Roche, making it a key adjacent incumbent in the lab ecosystem.
- Abbott Diagnostics: Major IVD platform provider offering chemistry, immunoassay, and point-of-care analyzers. Comparable as the type of analyzer manufacturer to which Motryx's QC validation is calibrated.
Emerging players
- Copan Diagnostics: Specializes in pre-analytical sample collection and transport systems, including automated specimen processing. Comparable to Motryx in focusing on sample quality and integrity in the pre-analytical phase of lab testing.
- Tasso: Develops connected, remote blood collection devices for decentralized clinical trials and home use. Comparable emerging player addressing sample quality in non-traditional, decentralized collection and transport settings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Motryx social profiles
Digital presenceMotryx financial estimates
Financial estimateRevenue estimate
Valuation estimate
Motryx leadership team
Management profileNumber of profiles
Profiles2 records
Motryx funding detail
Funding detailFunding overview
Funding rounds3 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Motryx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Motryx
What does Motryx do?
Motryx provides the VitalQC platform for clinically validating and continuously monitoring hospital pneumatic tube systems (PTS) used to transport blood samples. The platform combines the VitalVial hardware surrogate sample (a weight-matched blood-vial-form-factor device with embedded 3-axis accelerometers) with cloud-based VitalApp analytics and patented algorithms that translate transport vibration data into hemolysis index and analyte-specific sample rejection probability.
Is Motryx a public or private company?
Motryx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Motryx founded?
Motryx was founded in 2014. It employs 1 to 10 people.
Where is Motryx based?
Motryx is headquartered in Halifax, Canada, in the North America region.
How does Motryx make money?
Three revenue lines are on record. VitalQC Software/Subscription is the primary driver. The others are vitalVial Hardware and professional Services / Validation Services.
Who are Motryx's main competitors?
Direct peers on record are Bio-Rad Laboratories, Randox Laboratories, Streck and Quantimetrix. Broad incumbents are Becton, Dickinson and Company (BD), Greiner Bio-One, Roche Diagnostics and Abbott Diagnostics. Emerging players are Copan Diagnostics and Tasso.
Does Motryx have an API?
No public API is recorded for Motryx.
What industry is Motryx in?
Motryx's product category is Laboratory Pre-Analytical Quality Assurance Software. Its primary akta.pro industry code is HLAHAAAL, Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables), with a secondary code of HLAGAEAI, Sample Logistics, Biorepository & IVD Kit Management (Trial Support). Its NAICS code is 334516 and its SIC code is 3826.